These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3263334
1. In vivo mechanisms of alloreactivity--IV. Cyclosporine differentially impairs accumulation of donor-reactive CTL but not donor-reactive alloantibody in murine sponge matrix allografts. Orosz CG, Zinn NE, Sirinek LP, Ferguson RM. Int J Immunopharmacol; 1988; 10(3):305-16. PubMed ID: 3263334 [Abstract] [Full Text] [Related]
2. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis. Orosz CG, Zinn NE, Sirinek LP, Ferguson RM. Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879 [Abstract] [Full Text] [Related]
3. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts. Orosz CG, Zinn NE, Sirinek L, Ferguson RM. Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878 [Abstract] [Full Text] [Related]
4. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Transplantation; 1994 Sep 15; 58(5):576-84. PubMed ID: 7522364 [Abstract] [Full Text] [Related]
5. In vivo mechanisms of alloreactivity. III. Development of donor-specific antibody in sponge matrix allografts. Sirinek LP, Zinn NE, Ferguson RM, Orosz CG. Transplantation; 1986 Mar 15; 41(3):349-56. PubMed ID: 3952801 [Abstract] [Full Text] [Related]
6. In vivo mechanisms of alloreactivity. VI. Evidence that alloantigen deposition initiates both local and systemic mechanisms that influence CTL accumulation at a graft site. Orosz CG, Bishop DK, Ferguson RM. Transplantation; 1989 Nov 15; 48(5):818-24. PubMed ID: 2815254 [Abstract] [Full Text] [Related]
7. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction. Bowlin TL, Rosenberger AL, McKown BJ. Clin Exp Immunol; 1989 Jul 15; 77(1):151-6. PubMed ID: 2504519 [Abstract] [Full Text] [Related]
8. Inhibition of human in vivo cytotoxic T lymphocyte generation by cyclosporine following organ transplantation. Keown PA, Essery-Rice G, Hellstrom A, Sinclair NR, Stiller CR. Transplantation; 1985 Jul 15; 40(1):45-9. PubMed ID: 3892796 [Abstract] [Full Text] [Related]
9. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction. Orosz CG, Adams PW, Ferguson RM. Transplantation; 1988 Aug 15; 46(2 Suppl):73S-79S. PubMed ID: 2970141 [Abstract] [Full Text] [Related]
10. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK. J Immunol; 1996 Sep 15; 157(6):2310-9. PubMed ID: 8805628 [Abstract] [Full Text] [Related]
11. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts. Norin AJ, Kamholz SL. Transplantation; 1989 Nov 15; 48(5):856-62. PubMed ID: 2530670 [Abstract] [Full Text] [Related]
12. Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine. Noble RL, Steinmuller D. Transplantation; 1989 Feb 15; 47(2):322-6. PubMed ID: 2784016 [Abstract] [Full Text] [Related]
13. Immunosuppressive effects of cyclosporin A on cloned T cells. Herold KC, Lancki DW, Moldwin RL, Fitch FW. J Immunol; 1986 Feb 15; 136(4):1315-21. PubMed ID: 2935576 [Abstract] [Full Text] [Related]
14. Abrogation of T cell homing by alloantibody. Chang AE, Sugarbaker PH. Transplantation; 1980 Feb 15; 29(2):127-32. PubMed ID: 6986686 [Abstract] [Full Text] [Related]
15. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response. Norin AJ, Kamholz SL, Pinsker KL, Emeson EE, Veith FJ. J Immunol; 1987 Jul 15; 139(2):332-7. PubMed ID: 2955037 [Abstract] [Full Text] [Related]
16. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences. Miyagawa S, Stepkowski SM, Lawen JG, Rutzky LP, Kahan BD. Transplantation; 1991 Nov 15; 52(5):851-7. PubMed ID: 1835196 [Abstract] [Full Text] [Related]
17. The survival and nature of the immune response to soft-tissue and composite-tissue allografts in rats treated with low-dose cyclosporine. Sobrado L, Pollak R, Robichaux WH, Martin PC, Sullivan KA, Swartz WM. Transplantation; 1990 Sep 15; 50(3):381-5. PubMed ID: 2402786 [Abstract] [Full Text] [Related]
18. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. Lancki DW, Kaper BP, Fitch FW. J Immunol; 1989 Jan 15; 142(2):416-24. PubMed ID: 2492047 [Abstract] [Full Text] [Related]
19. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts. Yang CP, Shittu E, Bell EB. J Immunol; 2000 Mar 01; 164(5):2427-32. PubMed ID: 10679079 [Abstract] [Full Text] [Related]
20. Activation of alloreactive natural killer cells is resistant to cyclosporine. Petersson E, Qi Z, Ekberg H, Ostraat O, Dohlsten M, Hedlund G. Transplantation; 1997 Apr 27; 63(8):1138-44. PubMed ID: 9133476 [Abstract] [Full Text] [Related] Page: [Next] [New Search]